Cancer clinical trials in the region Normandie
97 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Prostate cancer
#NCT05848011
Adenocarcinoma
Metastatic Castration-resistant
Hormone therapy
Systemic Treatment-Naive
Chemotherapy
Immunotherapy
Hôpital Foch (Suresnes), Centre Hospitalier de Cornouaille (Quimper), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux) (and 5 more...)
MacroGenics
Phase 2
Lung cancer
#NCT05498428
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Systemic Treatment-Naive
Targeted therapy
Immunotherapy
Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Institut Curie - Paris (Paris), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Gustave Roussy (Villejuif) (and 1 more...)
Janssen
Phase 2
Lung cancer
#NCT05718297
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
ALK
Systemic Treatment-Naive
CHU Caen Normandie (Caen), Centre Hospitalier Universitaire Angers (Angers )
Takeda
Phase 2
Lung cancer
#NCT05609578
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
Chemotherapy
Immunotherapy
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
Targeted therapy
Targeted therapy
Centre Hospitalier Intercommunal Créteil (Créteil Cedex), Hôpital Larrey (Toulouse ), Hôpital Tenon AP-HP (Paris ), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut Paoli-Calmettes (Marseille) (and 5 more...)
Mirati Thérapeutique Inc.
Phase 2
Lung cancer
#NCT05856695
SCLC (Small Cell Lung Cancer)
Metastatic
Systemic Treatment-Naive
Centre Hospitalier d'Abbeville (Abbeville), Clinique de l'Europe d'Amiens (Amiens), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire de Bordeaux (Bordeaux) (and 22 more...)
Intergroupe Francophone de Cancérologie Thoracique
Phase 2
Lung cancer
#NCT05200481
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ALK
Systemic Treatment-Naive
BRAF
EGFR
KRAS G12C
KRAS non G12C
MET
NTRK-1/2/3
RET
ROS-1
Targeted therapy
Targeted therapy
Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Ambroise-Paré AP-HP (Boulogne-Billancourt), Hôpital Louis Pradel (Bron ), CHU Caen Normandie (Caen) (and 21 more...)
Intergroupe Francophone de Cancérologie Thoracique